Dry Needling and Rehabilitatin Carpal Tunnel Syndrome

Carpal Tunnel Syndrome Clinical Trial

Official title:

Dry Needling in Patients With Carpal Tunnel Syndrome

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06358326
• Other study ID #: Karabuk-1
• Status: Recruiting
• Phase: N/A
• Start date: April 5, 2024
• Est. completion date: September 30, 2024

Study information

• Verified date: April 2024
• Source: Karabuk University
• Contact: Musa Gunes, MsC
• Phone: 0 (370) 418 9081
• Email: musagunes[@]karabuk.edu.tr
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Dry needling is used for myofascial release. However, its effectiveness in carpal tunnel syndrome (CTS) is not well known. It is thought that dry needling may also be an effective treatment for CTS by providing relaxation in the fascial tissue. Therefore, this study will examine the effects of dry needling treatment on pain, function, range of motion, proprioception and disability in patients with CTS.

Description:

Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy in the society, which develops due to compression of the median nerve in the carpal tunnel. With the compression of the median nerve, a pain, numbness and tingling sensation spreading to the hand and wrist affects daily living activities and reduces the quality of life. Thickening and myofascial restriction in the carpal tunnel area also contribute to this situation. For this reason, various treatment methods have been developed for CTS, ranging from conservative treatment to surgery. Dry needling is also an alternative treatment method that can be used for CTS. Dry needling allows the fascial tissue to loosen and re-enter the healing process, leading to a decrease in pain and an increase in quality of life. However, its effectiveness in patients with CTS is unknown. This study aimed to examine the effectiveness of dry needling in patients with CTS.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: September 30, 2024
• Est. primary completion date: August 30, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

1. Volunteering to participate in the study.

2. Being between the ages of 18-65.

3. Being diagnosed with mild or moderate stage CTS as a result of the electroneurophysiological test.

Exclusion Criteria:

1. Having additional neurological, rheumatological and orthopedic disorders.

2. Having had previous hand surgery.

3. Having an additional acute neck, shoulder, elbow and hand problem.

4. Having a BMI of 40 kg/m2 and above.

5. Being pregnant.

6. As a result of the electroneurophysiological test, the data related to the median nerve are at a severe level.

Related Conditions & MeSH terms

• Carpal Tunnel Syndrome
• Dry Needling
• Facial Pain
• Myofacial Pain
• Syndrome

Intervention

Other:
• Dry needling
In addition to stretching, nerve mobilization and tendon gliding exercises, a total of 5 sessions of dry needling will be performed for fascial mobilization, 2 days a week for 3 weeks.
• Control group
The physiotherapist will teach stretching, neuromobilization and tendon shifting exercises and will be asked to do them regularly for 3 weeks.

Locations

Country	Name	City	State
Turkey	Pursaklar State Hospital	Ankara

Sponsors (1)

Lead Sponsor	Collaborator
Karabuk University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain severity	It will be evaluated with the Visual Analogue Scale. The scale ranges from 1 to 10 at 10 mm intervals. 0 indicates absence of pain and the highest value of 10 indicates extreme pain.	Baseline and 3 weeks post-intervention
Primary	Wrist range of motion	Wrist flexion, extension, ulnar deviation and radial deviation joint range degrees will be measured using a universal goniometer.	Baseline and 3 weeks post-intervention
Primary	Position sense	In the evaluation of joint position sense (proprioception), wrist extension, elbow flexion and shoulder flexion movements will be evaluated with an inclinometer. An increase in deviation from the target angle indicates a worsening of position sense.	Baseline and 3 weeks post-intervention
Primary	Severity of symptoms	The patients' CTS-related symptom severity and functional status will be evaluated with the Boston Carpal Tunnel Syndrome Questionnaire. The severity of the patient's strain is scored between 1-5. Higher scores indicate greater disability.	Baseline and 3 weeks post-intervention
Primary	Functional status	Upper Extremity Functional Index will be used to evaluate the functional disability of the upper extremity. Scoring ranges from 0 to 100 points, with a higher score indicating a higher activity level.	Baseline and 3 weeks post-intervention
Primary	Hands activity level	Duruöz hand index will be used to evaluate hand-related activity limitations. The survey yields a total score of 0-90, with a higher score indicating greater activity restriction.	Baseline and 3 weeks post-intervention
Primary	neuropathic pain severity	Neuropathic pain will be evaluated with the Neuropathic Pain Questionnaire. The change of 4 points determined as the neuropathic pain threshold will be examined.	Baseline and 3 weeks post-intervention
Primary	Nerve cross-sectional area	With ultrasonography, the doctor will measure the median nerve cross-sectional area of the individual and the distance between the median nerve flexor retinaculum.	Baseline and 3 weeks post-intervention